Davey Daniel
Hematology | Oncology
605 Glenwood Dr Ste 200
Chattanooga, TN 37404
Chattanooga, TN 37404
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.
Journal: Cancer research communications
Published: January 22, 2026
Impact of community recruitment and inclusion initiatives on enrollment in the biomarker-driven MyTACTIC trial.
Journal: Future oncology (London, England)
Published: December 15, 2025
Durvalumab Consolidation in Limited-Stage SCLC: Outcomes by Prior Concurrent Chemoradiotherapy and Prophylactic Cranial Irradiation in the Phase 3 ADRIATIC Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 04, 2025
A rising tide lifts all boats in the personalized cancer care continuum for mNSCLC: bridging inequities in NGS fosters equity in targeted treatment.
Journal: The oncologist
Published: December 18, 2024
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: September 13, 2024
Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 Trial.
Journal: JTO clinical and research reports
Published: July 16, 2024
Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in the US Community Setting.
Journal: JCO oncology practice
Published: January 09, 2024
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC.
Journal: JTO clinical and research reports
Published: September 29, 2023
Clinical Value of Timely Targeted Therapy for Patients With Advanced Non-Small Cell Lung Cancer With Actionable Driver Oncogenes.
Journal: The oncologist
Published: July 27, 2023
Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.
Journal: Future oncology (London, England)
Published: June 15, 2023
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.
Journal: Cancer discovery
Published: April 21, 2023
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC.
Journal: JTO clinical and research reports
Published: April 27, 2022
Last Updated: 09/26/2026